Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68788-7891

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68788-7891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A pharmacokinetic interaction chart showing the effect of various interacting drugs on venlafaxine. It displays fold changes in maximum concentration (Cmax) and area under the curve (AUC) with 90% confidence intervals, alongside clinical recommendations like dose adjustments and cautions for drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*

FDA Label Image

Figure2 (Figure2)

A pharmacokinetic interaction chart for venlafaxine hydrochloride showing PK fold changes and 90% confidence intervals for various interacting drugs and analytes. The chart compares Cmax and AUC changes relative to a reference value, with recommendations such as avoiding alcohol use and monitoring blood pressure for metoprolol, while other drugs show no dose adjustment needed or unknown clinical significance.*

FDA Label Image

Figure3 (Figure3)

A chart showing pharmacokinetic (PK) fold change and 90% confidence intervals in various special populations for venlafaxine and its metabolite ODV. Populations include hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 metabolizer status, age over 60, and gender. The horizontal axis represents change relative to reference value, with dosing recommendations on the right.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxine HCl Extended-release Capsules 37.5mg (Venlafaxine Hydrochloride 30 Capsules)

Label for Venlafaxine HCl Extended-Release Capsules 37.5 mg by Preferred Pharmaceuticals Inc. The label states it is generic for Effexor ER, with each capsule containing Venlafaxine Hydrochloride equivalent to 37.5 mg of Venlafaxine. Manufacturing information lists Camber Pharmaceuticals, Inc. in Piscataway, NJ. The label includes dosing instructions in English and Spanish and cautions about federal law prohibiting transfer of the drug to others.*

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure of Venlafaxine Hydrochloride showing the molecular arrangement including a chiral center, aromatic ring, and functional groups such as hydroxyl and methoxy groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.